What Are the Biomarkers for Glaucoma?

Survey of Ophthalmology

Volumn 52, Issue 6 SUPPL., 2007, Pages

  Golubnitschaja, Olga ^a   Flammer, Josef ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

disease transcriptomics and proteomics; disease specific gene expression patterns; DNA damage repair methylation status; gene hunting; glaucoma; neurodegeneration; non invasive early diagnosis

Indexed keywords

ANTIGLAUCOMA AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; DNA; HLA DR ANTIGEN; MUCIN 5AC; TREFOIL PEPTIDE;

APOPTOSIS; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; BLOOD; BLOOD BRAIN BARRIER; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; ENERGY METABOLISM; EYE; GENE EXPRESSION; GLAUCOMA; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STRESS; TRANSCRIPTION REGULATION;

APOPTOSIS; BIOLOGICAL MARKERS; CELL ADHESION; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE, MULTIPLE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLAUCOMA; HUMANS; PROTEOMICS;

EID: 35848944887     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.08.011     Document Type: Article

References (49)

1. Ahmed F., Brown K.M., Stephan D.A., et al. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci 45 (2004) 1247-1258
2. Bagrov A.Y., Dmitrieva R.I., Fedorova O.V., et al. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens 9 (1996) 982-990
3. Baudouin C., Garcher C., Haouat N., et al. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 101 (1994) 454-460
4. Bhattacharya S.K., Rockwood E.J., Smith S.D., et al. Proteomics reveal cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 280 (2005) 6080-6084
5. Bisoendial R.J., Hovingh G.K., Levels J.H., et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107 (2003) 2944-2948
6. Bruttini M., Longo I., Frezzotti P., et al. Mutations in the myocilin gene in families with primary open-angle glaucoma and juvenile open-angle glaucoma. Arch Ophthalmol 121 (2003) 1034-1038
7. de la Monte S.M., Xu Y.Y., Hutchins G.M., et al. Developmental patterns of neuronal thread protein gene expression in Down syndrome. J Neurol Sci 135 (1996) 118-125
8. de Souza G.A., Godoy L.M., and Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 7 (2006) R72
9. Diskin S., Kumar J., Cao Z., et al. Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 47 (2006) 1491-1499
10. Esser J., Esser P., Mietz H., et al. Multidrug resistance-associated proteins in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 238 (2000) 727-732
11. Flammer J., and Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy?. Surv Ophthalmol 52 Suppl (2007) S162-S173
12. Flammer J., Pache M., and Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 20 (2001) 319-349
13. Fleenor D.L., Pang I.H., and Clark A.F. Involvement of AP-1 in interleukin-1alpha-stimulated MMP-3 expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 44 (2003) 3494-3501
14. Golubnitschaja O., and Fountoulakis M. Gene hunting by substractive hybridisation in down syndrome; correlation with proteomics analysis. In: Mandel S. (Ed). Handbook of Neurochemistry and Molecular Neurobiology, vol. 25: Genomics, Proteomics and the Nervous System. ed 3. (2007), Kluwer Academic/Plenum Publishers, London, UK 346-358
15. Golubnitschaja O., Wunderlich K., Decker C., et al. Molecular imaging of perfusion disturbances in glaucoma. Amino Acids 23 (2002) 293-299
16. Golubnitschaja O., Yeghiazaryan K., Liu R., et al. Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients. J Glaucoma 13 (2004) 66-72
17. Golubnitschaja O., Yeghiazaryan K., Wunderlich K., et al. Disease proteomics reveals altered basic gene expression regulation in leukocytes of glaucoma patients. Proteomics-Clinical Applications (2007) (In press)
18. Golubnitschaja-Labudova O., Liu R., Decker C., et al. Altered gene expression in lymphocytes of patients with normal-tension glaucoma. Curr Eye Res 21 (2000) 867-876
19. Gong G., Kosoko-Lasaki O., Haynatzki G.R., et al. Genetic dissection of myocilin glaucoma. Hum Mol Genet 13 Spec No 1 (2004) R91-R102
20. Grieshaber M.C., and Flammer J. Does the blood-brain-barrier play a role in glaucoma?. Surv Ophthalmol 52 Suppl (2007) S115-S121
21. Grus F.H., Joachim S.C., Bruns K., et al. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 47 (2006) 968-976
22. Herndon L.W., Challa P., and Allingham R.R. Glaucoma in Ghana, West Africa: clinical features and the role of mutations in Myocilin. Ophthalmol Clin North Am 16 (2003) 631-637
23. Joyce C.W., Amar M.J., Lambert G., et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 99 (2002) 407-412
24. Kanagavalli J., Krishnadas S.R., Pandaranayaka E., et al. Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients. Mol Vis 9 (2003) 606-614
25. Kotikoski H., Moilanen E., Vapaatalo H., et al. Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients. Acta Ophthalmol Scand 80 (2002) 191-195
26. Melki R., Idhajji A., Driouiche S., et al. Mutational analysis of the Myocilin gene in patients with primary open-angle glaucoma in Morocco. Ophthalmic Genet 24 (2003) 153-160
27. Migliore L., Fontana I., Colognato R., et al. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol Aging 26 (2005) 587-595
28. Moenkemann H., Flammer J., Wunderlich K., et al. Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids 28 (2005) 199-205
29. Mohan R., Rinehart W.B., Bargagna-Mohan P., et al. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J Biol Chem 273 (1998) 25903-25914
30. Ognibene A., Ciuti R., Tozzi P., et al. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies. Prenat Diagn 19 (1999) 1058-1060
31. Pang I.H., Fleenor D.L., Hellberg P.E., et al. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest Ophthalmol Vis Sci 44 (2003) 3502-3510
32. Pechere-Bertschi A., Sunaric-Megevand G., Haefliger I.O., et al. Renal sodium handling in patients with normal pressure glaucoma. Clin Sci (Lond) 112 (2007) 337-364
33. Reddy A.B., Panicker S.G., Mandal A.K., et al. Identification of R368H as a predominant CYP1B1 allele causing primary congenital glaucoma in Indian patients. Invest Ophthalmol Vis Sci 44 (2003) 4200-4203
34. Salomon P., Mysiak A., and Halawa B. [Sodium efflux through lymphocytic cell membranes in patients with acute myocardial infarction]. Pol Arch Med Wewn 100 (1998) 543-550
35. Schmutzler R.K., Rhiem K., Breuer P., et al. Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 15 (2006) 483-489
36. Schwartz B., Abrahamson R., Takamoto T., et al. Association of ocular pressure and optic disc cup volume with red blood cell sodium-potassium ATPase inhibition. Curr Eye Res 21 (2000) 897-905
37. Silva J.E. Thyroid hormone control of thermogenesis and energy balance. Thyroid 5 (1995) 481-492
38. Souchier M., Buron N., Lafontaine P.O., et al. Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?. Br J Ophthalmol 90 (2006) 1366-1369
39. Sripriya S., Uthra S., Sangeetha R., et al. Low frequency of myocilin mutations in Indian primary open-angle glaucoma patients. Clin Genet 65 (2004) 333-337
40. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 205 (2005) 1-16
41. Tatton W., Chen D., Chalmers-Redman R., et al. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv Ophthalmol 48 Suppl 1 (2003) S25-S37
42. Tezel G., Yang X., and Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 46 (2005) 3177-3187
43. Tomarev S.I., Wistow G., Raymond V., et al. Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. Invest Ophthalmol Vis Sci 44 (2003) 2588-2596
44. Valdemarsson S., Ikomi-Kumm J., and Monti M. Increased lymphocyte thermogenesis in hyperthyroid patients. Role of Na/K pump function. Evaluation of aerobic/anaerobic metabolism. Acta Endocrinol (Copenh) 126 (1992) 291-295
45. van den Bergh W.M., Dijkhuizen R.M., and Rinkel G.J. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 17 (2004) 301-313
46. Wiggs J.L., Auguste J., Allingham R.R., et al. Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma. Arch Ophthalmol 121 (2003) 118-3
47. Wunderlich K., Golubnitschaja O., Pache M., et al. Increased plasma levels of 20S proteasome alpha-subunit in glaucoma patients: an observational pilot study. Mol Vis 8 (2002) 431-435
48. Yang J., Patil R.V., Yu H., et al. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol 131 (2001) 421-426
49. Yeghiazaryan K., Flammer J., Wunderlich K., et al. An enhanced expression of ABC 1 transporter in circulating leukocytes as a potential molecular marker for the diagnostics of glaucoma. Amino Acids 28 (2005) 207-211